Skip to main content
logo
Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,199.43
-30.50 (-2.48%)
At close: Jun 30, 2026, 4:00 PM EDT
1,200.71
+1.28 (0.11%)
After-hours: Jun 30, 2026, 7:59 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20
Basaglar Revenue
206.00M
Basaglar Revenue Growth
18.66%
Humalog Revenue
442.00M
Humalog Revenue Growth
-17.72%
Humulin Revenue
160.00M
Humulin Revenue Growth
-7.62%
Jardiance Revenue
1.11B
Jardiance Revenue Growth
9.82%
Mounjaro Revenue
8.66B
Mounjaro Revenue Growth
125.47%
Trajenta Revenue
76.00M
Trajenta Revenue Growth
-0.39%
Trulicity Revenue
919.00M
Trulicity Revenue Growth
-16.09%
Zepbound Revenue
4.16B
Zepbound Revenue Growth
79.94%
Other Cardiometabolic Health Revenue
22.00M
Cardiometabolic Health Revenue
15.76B
Cardiometabolic Health Revenue Growth
71.15%
Oncology Revenue
2.27B
Oncology Revenue Growth
16.46%
Immunology Revenue
1.20B
Immunology Revenue Growth
10.57%
Neuroscience Revenue
382.00M
Neuroscience Revenue Growth
40.39%
Other Product Revenue
187.00M
Other Product Revenue Growth
-12.16%
Revenue (Other)
-1.00M
Revenue (Total)
19.80B
Revenue (Total) Growth
55.54%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20
US Revenue
12.12B
US Revenue Growth
42.75%
Europe Revenue
3.65B
Europe Revenue Growth
52.63%
Japan Revenue
571.00M
Japan Revenue Growth
41.97%
China Revenue
693.00M
China Revenue Growth
53.73%
Other Foreign Countries Revenue
2.77B
Other Foreign Countries Revenue Growth
177.82%
Revenue (Other)
-1.00M
Revenue (Total)
19.80B
Revenue (Total) Growth
55.54%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20
Revenue Change due to Price
-13.00%
Revenue Change due to Volume
65.00%
Revenue Change due to FX
4.00%